Estimation of insulin sensitivity in children: Methods, measures and controversies

Pediatric Diabetes

Volumn 15, Issue 3, 2014, Pages 151-161

  Brown, Rebecca J ^a   Yanovski, Jack A ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

FSIGT; Glucose clamp technique; Glucose tolerance; HOMA; Insulin sensitivity; QUICKI; Surrogate measures

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; PROINSULIN; ROSIGLITAZONE; SOMATOSTATIN DERIVATIVE; BIOLOGICAL MARKER;

ANALYTIC METHOD; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CHILD; CLINICAL ASSESSMENT; CROSS REACTION; DIET RESTRICTION; DISEASE MARKER; FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE TOLERANCE TEST; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAVENOUS GLUCOSE TOLERANCE TEST; LABORATORY TEST; MALNUTRITION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PEDIATRICS; PRIORITY JOURNAL; REPRODUCIBILITY; VALIDATION STUDY; ADOLESCENT; BLOOD; NUTRITIONAL ASSESSMENT;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; NUTRITION ASSESSMENT; VALIDATION STUDIES AS TOPIC;

EID: 84900451432     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12146     Document Type: Article

References (74)

1. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979: 237: E214-E223.
2. Levy-Marchal C, Arslanian S, Cutfield W et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010: 95: 5189-5198.
3. Bell GI, Kayano T, Buse JB et al. Molecular biology of mammalian glucose transporters. Diabetes care 1990: 13: 198-208.
4. DeFronzo RA. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 1992: 35: 389-397.
5. Robbins DC, Andersen L, Bowsher R et al. Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 1996: 45: 242-256.
6. Miller WG, Thienpont LM, Van Uytfanghe K et al. Toward standardization of insulin immunoassays. Clin Chem 2009: 55: 1011-1018.
7. Chevenne D, Letailleur A, Trivin F, Porquet D. Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA. Clin Chem 1998: 44: 354-356.
8. Gambino R. Sodium fluoride: an ineffective inhibitor of glycolysis. Ann Clin Biochem 2013: 50: 3-5.
9. Sacks DB, Arnold M, Bakris GL et al. Executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011: 57: 793-798.
10. Wilkerson HL, Hyman H, Kaufman M, Mc CA, Francis JO. Diagnostic evaluation of oral glucose tolerance tests in nondiabetic subjects after various levels of carbohydrate intake. N Engl J Med 1960: 262: 1047-1053.
11. Buhling KJ, Elsner E, Wolf C et al. No influence of high- and low-carbohydrate diet on the oral glucose tolerance test in pregnancy. Clin Biochem 2004: 37: 323-327.
12. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002: 51: 3014-3019.
13. Arslanian SA, Kalhan SC. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes 1994: 43: 908-914.
14. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present? J Clin Endocrinol Metab 1996: 81: 1058-1062.
15. Arslanian S, Suprasongsin C, Janosky JE. Insulin secretion and sensitivity in black versus white prepubertal healthy children. J Clin Endocrinol Metab 1997: 82: 1923-1927.
16. Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 2012: 61: 2787-2795.
17. Lee S, Kim Y, White DA, Kuk JL, Arslanian S. Relationships between insulin sensitivity, skeletal muscle mass and muscle quality in obese adolescent boys. Eur J Clin Nutr 2012: 66: 1366-1368.
18. Sjaarda LG, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr 2012: 161: 51-57.
19. Giannini C, Weiss R, Cali A et al. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes 2012: 61: 606-614.
20. Moran A, Jacobs DR Jr, Steinberger J et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999: 48: 2039-2044.
21. Sjaarda LA, Michaliszyn SF, Lee S et al. HbA(1c) diagnostic categories and beta-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care 2012: 35: 2559-2563.
22. Davey RJ, Howe W, Paramalingam N et al. The effect of midday moderate-intensity exercise on postexercise hypoglycemia risk in individuals with type 1 diabetes. J Clin Endocrinol Metab 2013: 98: 2908-2914.
23. Rathsman B, Rosfors S, Sjoholm A, Nystrom T. Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol 2012: 11: 145.
24. Bacha F, Gungor N, Lee S, Arslanian SA. Progressive deterioration of beta-cell function in obese youth with type 2 diabetes. Pediatr Diabetes 2013: 14: 106-111.
25. Petryk A, Baker KS, Frohnert B et al. Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors. Pediatr Blood Cancer 2013: 60: 467-473.
26. Verbruggen SC, Coss-Bu J, Wu M et al. Current recommended parenteral protein intakes do not support protein synthesis in critically ill septic, insulin-resistant adolescents with tight glucose control. Crit Care Med 2011: 39: 2518-2525.
27. Arslanian SA. Clamp techniques in paediatrics: what have we learned? Horm Res 2005: 64 (Suppl 3): 16-24.
28. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006: 60: 759-763.
29. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008: 294: E15-E26.
30. Del Prato S, Bonadonna RC, Bonora E et al. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 1993: 91: 484-494.
31. Matsuda M, DeFronzo RA. In vivo measurement of insulin sensitivity in humans. In: Draznin B, Rizza RA, eds. Clinical Research in Diabetes and Obesity, Part I: Methods, Assessment, and Metabolic Regulation. Totowa: Humana Press, Inc., 1997: 23-65.
32. Krentz AJ, Boyle PJ, Macdonald LM, Schade DS. Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations. Metabolism 1994: 43: 24-31.
33. Matsuda M, DeFronzo R. In vivo measurement of insulin sensitivity in humans. In: Draznin B, Rizza R, eds. Clinical Research in Diabetes and Obesity, Part I: Methods, Assessment, and Metabolic Regulation. Totowa: Humana Press, 1997: 23-65.
34. Arslanian SA. Clamp techniques in paediatrics: what have we learned? Horm Res 2005: 64 (Suppl. 3): 16-24.
35. Bonora E, Moghetti P, Zancanaro C et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989: 68: 374-378.
36. Reaven GM. Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured? Am J Med 1983: 74: 3-17.
37. Gelding SV, Robinson S, Lowe S, Niththyananthan R, Johnston DG. Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol (Oxf) 1994: 40: 611-615.
38. Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 2005: 54: 1994-2002.
39. Cochran E, Young JR, Sebring N, DePaoli A, Oral EA, Gorden P. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. J Clin Endocrinol Metab 2004: 89: 1548-1554.
40. Sarnblad S, Kroon M, Aman J. The short insulin tolerance test lacks validity in adolescents with Type 1 diabetes. Diabet Med 2002: 19: 51-56.
41. Mitrakou A, Vuorinen-Markkola H, Raptis G et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab 1992: 75: 379-382.
42. Uwaifo GI, Parikh SJ, Keil M, Elberg J, Chin J, Yanovski JA. Comparison of insulin sensitivity, clearance, and secretion estimates using euglycemic and hyperglycemic clamps in children. J Clin EndocrinolMetab 2002: 87: 2899-2905.
43. Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002: 25: 2081-2087.
44. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981: 68: 1456-1467.
45. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979: 236: E667-E677.
46. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993: 42: 250-256.
47. Tompkins CL, Cefalu W, Ravussin E et al. Feasibility of intravenous glucose tolerance testing prior to puberty. Int J Pediatr Obes 2010: 5: 51-55.
48. Cruz ML, Weigensberg MJ, Bergman RN, Goran MI. Frequency of hypoglycaemia during the intravenous glucose tolerance test in overweight children. Int J Pediatr Obes 2007: 2: 122-125.
49. Saad MF, Anderson RL, Laws A et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 1994: 43: 1114-1121.
50. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000: 85: 2402-2410.
51. Pillonetto G, Sparacino G, Magni P, Bellazzi R, Cobelli C. Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals. Am J Physio Endocrinol Metab 2002: 282: E564-E573.
52. Coates PA, Luzio SD, Brunel P, Owens DR. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 1995: 44: 631-635.
53. Brandou F, Brun JF, Mercier J. Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab 2005: 90: 761-767.
54. Rossner SM, Neovius M, Montgomery SM, Marcus C, Norgren S. Alternative methods of insulin sensitivity assessment in obese children and adolescents. Diabetes Care 2008: 31: 802-804.
55. Cutfield WS, Jefferies CA, Jackson WE, Robinson EM, Hofman PL. Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes 2003: 4: 119-125.
56. Goran MI, Bergman RN, Cruz ML, Watanabe R. Insulin resistance and associated compensatory responses in african-american and Hispanic children. Diabetes Care 2002: 25: 2184-2190.
57. Adler-Wailes DC, Periwal V, Ali AH et al. Sex-associated differences in free fatty acid flux of obese adolescents. J Clin Endocrinol Metab 2013: 98: 1676-1684.
58. Henderson M, Rabasa-Lhoret R, Bastard JP et al. Measuring insulin sensitivity in youth: how do the different indices compare with the gold-standard method? Diabetes Metab 2011: 37: 72-78.
59. Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998: 63: 134-141.
60. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999: 22: 1462-1470.
61. Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001: 24: 796-797.
62. Gutt M, Davis CL, Spitzer SB et al. Validation of the insulin sensitivity index (ISI(0, 120)): comparison with other measures. Diabetes Res Clin Pract 2000: 47: 177-184.
63. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 2003: 88: 1019-1023.
64. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 2001: 50: 150-158.
65. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008: 93: 4231-4237.
66. Gustafson JK, Yanoff LB, Easter BD et al. The stability of metabolic syndrome in children and adolescents. J Clin Endocrinol Metab 2009: 94: 4828-4834.
67. George L, Bacha F, Lee S, Tfayli H, Andreatta E, Arslanian S. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 2011: 96: 2136-2145.
68. Yeckel CW, Weiss R, Dziura J et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004: 89: 1096-1101.
69. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004: 27: 1487-1495.
70. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004: 144: 47-55.
71. Schwartz B, Jacobs DR Jr, Moran A, Steinberger J, Hong CP, Sinaiko AR. Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabetes Care 2008: 31: 783-788.
72. Dabelea D, D'Agostino RB Jr, Mason CC et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2011: 54: 78-86.
73. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000: 49: 626-632.
74. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY. Diabetes Care 2013: 36: 1749-1757.